Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation:

Elissa M Ozanne1, Geoffrey D Barnes2, Juan P Brito3

  • 1Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA elissa.ozanne@hsc.utah.edu.

BMJ (Clinical Research Ed.)
|January 9, 2025
PubMed

Insights

Decision aids for stroke prevention in non-valvular atrial fibrillation significantly improve shared decision-making, patient knowledge, and reduce decisional conflict. Using these aids, alone or combined, offers advantages over usual care.

Area of Science:

  • Cardiology
  • Health Services Research
  • Patient Decision Making

Background:

  • Non-valvular atrial fibrillation (NVAF) poses a significant stroke risk.
  • Effective stroke prevention in NVAF requires shared decision-making between patients and clinicians.
  • Existing decision support tools may vary in their impact on shared decision-making quality.

Purpose of the Study:

  • To assess the effectiveness of patient decision aids and clinician encounter decision aids in enhancing shared decision-making for stroke prevention in NVAF patients.
  • To evaluate the impact of these decision aids on patient knowledge and decisional conflict.

Main Methods:

  • A cluster randomized controlled trial involving 1117 patients with NVAF across six US academic medical centers.
  • Patients and clinicians were randomized to receive either a decision aid (patient-facing or clinician-facing) or usual care.
  • Primary outcomes included quality of shared decision-making (OPTION12), patient knowledge, and decisional conflict.

Main Results:

  • Combined use of patient and encounter decision aids significantly improved shared decision-making quality, patient knowledge, and reduced decisional conflict compared to usual care.
  • Both patient decision aids and encounter decision aids used individually also showed significant benefits for shared decision-making and knowledge.
  • No significant differences were found in treatment choices or patient satisfaction, nor in visit length.

Conclusions:

  • Decision aids, whether patient-facing, clinician-facing, or combined, enhance shared decision-making, patient knowledge, and reduce decisional conflict in NVAF stroke prevention.
  • The study demonstrates the advantage of using pre-visit or in-visit decision aids over usual care.
  • These findings support the integration of decision aids into clinical practice for NVAF management.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
621
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482